Merck & Co., Inc. — Director's Dealing 2018

Nov 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-10-30

Reporting Person: Scholefield James H (EVP,Chief Info&Digital Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-30	Restricted Stock Unit	$	A	34308.0000	Acquired	2021-10-30	Common Stock (34308.0000)	Direct
2018-10-30	Stock Option (right to buy)	$72.8700	A	47456.0000	Acquired	2028-10-29	Common Stock (47456.0000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.

F3: The option vests and becomes exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.